TW200635880A - Manufacture process of organic compounds - Google Patents

Manufacture process of organic compounds

Info

Publication number
TW200635880A
TW200635880A TW094144576A TW94144576A TW200635880A TW 200635880 A TW200635880 A TW 200635880A TW 094144576 A TW094144576 A TW 094144576A TW 94144576 A TW94144576 A TW 94144576A TW 200635880 A TW200635880 A TW 200635880A
Authority
TW
Taiwan
Prior art keywords
organic compounds
manufacture process
preparing
relates
present
Prior art date
Application number
TW094144576A
Other languages
English (en)
Inventor
Bernhard Riss
Ulrich Meier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34090175&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200635880(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TW200635880A publication Critical patent/TW200635880A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
TW094144576A 2004-12-16 2005-12-15 Manufacture process of organic compounds TW200635880A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0427603.6A GB0427603D0 (en) 2004-12-16 2004-12-16 Organic compounds

Publications (1)

Publication Number Publication Date
TW200635880A true TW200635880A (en) 2006-10-16

Family

ID=34090175

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094144576A TW200635880A (en) 2004-12-16 2005-12-15 Manufacture process of organic compounds

Country Status (24)

Country Link
US (1) US8461385B2 (zh)
EP (2) EP2955171A1 (zh)
JP (1) JP5224816B2 (zh)
KR (1) KR101287233B1 (zh)
CN (1) CN101080384B (zh)
AR (1) AR055007A1 (zh)
AU (1) AU2005315850B2 (zh)
BR (1) BRPI0519327A2 (zh)
CA (1) CA2587213C (zh)
ES (1) ES2547349T3 (zh)
GB (1) GB0427603D0 (zh)
GT (1) GT200500353A (zh)
IL (1) IL183366A0 (zh)
MA (1) MA29092B1 (zh)
MX (1) MX2007007211A (zh)
NO (1) NO338969B1 (zh)
PE (1) PE20060740A1 (zh)
PL (1) PL1838664T3 (zh)
PT (1) PT1838664E (zh)
RU (1) RU2404158C2 (zh)
TN (1) TNSN07229A1 (zh)
TW (1) TW200635880A (zh)
WO (1) WO2006063821A1 (zh)
ZA (1) ZA200703826B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007035718A2 (en) * 2005-09-19 2007-03-29 Emisphere Technologies, Inc. Crystalline forms of the di-sodium salt of n-(5-chlorosalicyloyl)-8-aminocaprylic acid
BRPI0817396C8 (pt) 2007-11-02 2021-05-25 Emisphere Tech Inc composição farmacêutica para tratar deficiência de vitamina b¹²
CN109473182B (zh) * 2018-11-12 2021-10-19 北京北排科技有限公司 一种基于深度信念网络的mbr膜透水率智能检测方法
ES2952567T3 (es) * 2019-05-20 2023-11-02 Lonza Guangzhou Pharmaceutical Ltd Método para la preparación de Carsalam
CN115260116B (zh) * 2022-08-19 2024-04-12 株洲壹诺生物技术有限公司 8-(2-羟基苯甲酰胺基)辛酸钠及苯并噁嗪-2,4-二酮和8-溴辛酸乙酯的制法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60017888T2 (de) * 1999-04-05 2006-01-19 Emisphere Technologies, Inc. Dinatrium-salze, monohydrate und ethanol-solvate
JP2003503381A (ja) * 1999-06-25 2003-01-28 ザ インスティテューツ フォア ファーマスーティカル ディスカヴァリー エルエルシー 置換フェノキシ酢酸
JP4799794B2 (ja) * 2000-03-21 2011-10-26 エミスフェアー・テクノロジーズ・インク ジカルボキシル化中間体を介してアルキル化サリチルアミドを調製する方法。
US7262325B2 (en) 2000-06-02 2007-08-28 Emisphere Technologies, Inc. Method of preparing salicylamides
MXPA02012855A (es) * 2000-06-29 2004-04-20 Emisphere Tech Inc Compuestos y composiciones para suministrar agentes activos.
EP1322595B1 (en) * 2000-09-06 2008-05-28 Emisphere Technologies, Inc. (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
JP4508646B2 (ja) * 2002-01-09 2010-07-21 エミスフェアー・テクノロジーズ・インク 4−[(4−クロロ−2−ヒドロキシベンゾイル)アミノ]ブタン酸ナトリウムの多形体
ES2614603T3 (es) * 2002-02-20 2017-06-01 Emisphere Technologies, Inc. Procedimiento de administración de moléculas GLP-1
US20050054557A1 (en) 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin

Also Published As

Publication number Publication date
EP1838664B1 (en) 2015-07-15
CA2587213C (en) 2015-05-19
MX2007007211A (es) 2007-08-15
GT200500353A (es) 2006-07-17
CA2587213A1 (en) 2006-06-22
RU2007126972A (ru) 2009-01-27
KR101287233B1 (ko) 2013-07-17
JP5224816B2 (ja) 2013-07-03
NO20073548L (no) 2007-09-17
US20090253811A1 (en) 2009-10-08
CN101080384A (zh) 2007-11-28
ZA200703826B (en) 2008-08-27
PE20060740A1 (es) 2006-09-04
IL183366A0 (en) 2007-09-20
US8461385B2 (en) 2013-06-11
NO338969B1 (no) 2016-11-07
BRPI0519327A2 (pt) 2009-01-13
AU2005315850B2 (en) 2009-11-05
EP2955171A1 (en) 2015-12-16
PL1838664T3 (pl) 2016-04-29
MA29092B1 (fr) 2007-12-03
AR055007A1 (es) 2007-08-01
CN101080384B (zh) 2011-06-15
JP2008524142A (ja) 2008-07-10
KR20070086276A (ko) 2007-08-27
PT1838664E (pt) 2015-10-16
GB0427603D0 (en) 2005-01-19
WO2006063821A1 (en) 2006-06-22
AU2005315850A1 (en) 2006-06-22
RU2404158C2 (ru) 2010-11-20
ES2547349T3 (es) 2015-10-05
EP1838664A1 (en) 2007-10-03
TNSN07229A1 (en) 2008-11-21

Similar Documents

Publication Publication Date Title
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
EE04911B1 (et) Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks
CY1117449T1 (el) Φαινυλιουχα ν-ακυλο παραγωγα αμινων και αμινοξεων, μεθοδοι για την παραγωγη αυτων, μια φαρμακευτικη συνθεση και η χρηση αυτων
TNSN07228A1 (en) Manufacture process of organic compounds
IS2582B (is) Afleiður af N-(arýlsúlfónýl)beta-amínósýrum sem samanstanda af setnum amínómetýl hópi, aðferð til framleiðslu á afleiðum og lyfjafræðilegar samsetningar sem innihalda þær
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
TW200635880A (en) Manufacture process of organic compounds
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
MXPA05013751A (es) Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales.
CY1113871T1 (el) Διαδικασια παρασκευης γκαμπαπεντινης
DK1341749T3 (da) Fremgangsmåde til fremstilling af gabapentin
TW200719889A (en) Amino acid derivatives
JO3684B1 (ar) صور متبلرة من الملح ثنائي الصوديوم لحمض n-(5-كلورو ساليسلويل)-8-امينو كابريليك
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
MXPA05003355A (es) Composicion farmaceutica que comprende semihidrato de metansulfonato de sibutramina cristalino.
IL189286A0 (en) Novel cysteine protease inhibitors and their therapeutic applications
RS63804A (en) Stable salts of o-acetylsalicylic acid containing basic amino acids ii
NO20025124D0 (no) Metode
MXPA05010398A (es) Nuevo metodo para la sintesis del acido (2s)-indolin-2-carboxilico y aplicacion de mismo en la sintesis del perindopril.
RS20050272A (en) Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
EA200800044A1 (ru) Производные 2,5-бисдиамин[1,4]бензохинона
BRPI0406970A (pt) Modificação cristalina de um complexo de manganês
RS20060049A (en) Novel n-substituted indolyl-3-glycoxylic acid amides, use thereof as a medicament and method for the production thereof
SI2069323T1 (sl) Postopki za pripravo N-(2-acetil-4,6-dimetilfenil)-3-(((3,4-dimetil- 5-izoksazolil)amino)sulfonil)-2-tiofenkarboksamida
TH79797B (th) กระบวนการผลิตสารอินทรีย์